CVC Capital Partners weighs $2 billion sale of Arthea

CVC has tapped investment banks Moelis and William Blair to navigate the sale process, though discussions remain in the preliminary stages. The company, headquartered in White Plains, New York, recently rebranded from PDC—an acronym for Parfums de Coeur—to Arthea, signaling a shift toward a broader "art and healing" identity. Beyond its flagship Dr. Teal’s bath products, the firm manages a diverse stable of brands including Bodycology, Cantu, and fragrance lines like Body Fantasies, with distribution spanning more than 80 countries.

This potential divestment arrives amid a flurry of activity in the beauty and personal care sector. Recent months have seen L'Oreal finalize its $4.7 billion acquisition of Kering’s beauty unit and KKR-backed Wella Company file for a U.S. IPO. Should CVC reach a deal, it will mark one of the most significant consumer-goods transactions of the year, providing a clear litmus test for investor appetite in mid-market personal care platforms.